Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2003
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxvirusesEric Prieur, Sarah C Gilbert, Joerg Schneider, et al.
Scientific Reports|March 15, 2013
Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1Teresa Lambe, John B Carey, Yuanyuan Li, et al.
Scientific Reports|April 3, 2020
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling moleculeChristine S Rollier, Alexandra J Spencer, Karen Colbjorn Sogaard, et al.
Vaccine|April 20, 2006
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic areaPhilip Bejon, Jedidah Mwacharo, Oscar K Kai, et al.
Plos One|July 19, 2012
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityMatthew D J Dicks, Alexandra J Spencer, Nick J Edwards, et al.
Frontiers in Immunology|September 10, 2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus ChallengeMeagan McMahon, Guha Asthagiri Arunkumar, Wen-Chun Liu, et al.
Nature Medicine|July 29, 2008
Effective induction of high-titer antibodies by viral vector vaccinesSimon J Draper, Anne C Moore, Anna L Goodman, et al.
The Journal of Infectious Diseases|June 8, 2004
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian menVasee S Moorthy, Egeruan B Imoukhuede, Sheila Keating, et al.
Vaccines|September 28, 2024
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell VaccineEdmund G-T Wee, Sarah Kempster, Deborah Ferguson, et al.
Vaccines|March 27, 2026
Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane DomainsMarta Ulaszewska, Ji Ma, Susan J Morris, et al.
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2003
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxvirusesEric Prieur, Sarah C Gilbert, Joerg Schneider, et al.
Scientific Reports|March 15, 2013
Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1Teresa Lambe, John B Carey, Yuanyuan Li, et al.
Scientific Reports|April 3, 2020
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling moleculeChristine S Rollier, Alexandra J Spencer, Karen Colbjorn Sogaard, et al.
Vaccine|April 20, 2006
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic areaPhilip Bejon, Jedidah Mwacharo, Oscar K Kai, et al.
Plos One|July 19, 2012
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityMatthew D J Dicks, Alexandra J Spencer, Nick J Edwards, et al.
Frontiers in Immunology|September 10, 2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus ChallengeMeagan McMahon, Guha Asthagiri Arunkumar, Wen-Chun Liu, et al.
Nature Medicine|July 29, 2008
Effective induction of high-titer antibodies by viral vector vaccinesSimon J Draper, Anne C Moore, Anna L Goodman, et al.
The Journal of Infectious Diseases|June 8, 2004
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian menVasee S Moorthy, Egeruan B Imoukhuede, Sheila Keating, et al.
Vaccines|September 28, 2024
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell VaccineEdmund G-T Wee, Sarah Kempster, Deborah Ferguson, et al.
Vaccines|March 27, 2026
Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane DomainsMarta Ulaszewska, Ji Ma, Susan J Morris, et al.
Pageof 22